PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-Dec-2024 Global Outsourced Testing Services Market Poised for Significant Growth, expand at a CAGR of 7.7% to reach USD 76.3 Billion by the year 2032   MARKITWIRED
05-Dec-2024 Global Endoscope Detergents and Disinfectants Market Projected to Reach USD 1,108.2 Million by 2032 secure a CAGR of 4.4% MARKITWIRED
05-Dec-2024 Global Facial Erythema Treatment Market is projected to reach USD 299 Million by 2032 growing at a 5.1% CAGR MARKITWIRED
05-Dec-2024 Global Molecular Cytogenetics Market Set for Remarkable Surge: Projected to Reach USD 6,469.2 Million by 2032 forecast a CAGR of 8.9% MARKITWIRED
05-Dec-2024 Global Liposuction Surgery Devices Market Poised for Remarkable Growth USD 8.9 Million by 2033 at a robust CAGR of 11.6% MARKITWIRED
05-Dec-2024 Global Hearing Aids Market Poised for Steady Growth to see a Valuation of USD 10.98 Billion through 2034 MARKITWIRED
05-Dec-2024 Global Intraoperative Radiation Therapy Systems Market to Witness Robust Growth, Projected to Reach USD 124.7 Million by 2033 MARKITWIRED
05-Dec-2024 Global Hemostasis Testing Systems Market Expected to Reach USD 3,666 Million by 2033 expect a CAGR of 5.5% MARKITWIRED
04-Dec-2024 Real Endpoints Named a Fierce Healthcare Innovation Awards Winner in the Financial/Operational Solutions Category Newswire
04-Dec-2024 Supreme Group Acquires Amendola, an Award-Winning Healthcare, Health Tech and Life Sciences PR and Marketing Agency Amendola Communications, Part of Supreme Group
04-Dec-2024 Almirall launches The Hive, creating a novel collaborative innovation hub to advance life sciences and healthcare Almirall
04-Dec-2024 Celerion Pledges Commitment to the Science Based Targets Initiative (SBTi) Net-Zero Standard Celerion
04-Dec-2024 Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Everest Medicines Limited
04-Dec-2024 Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers Tiziana Life Sciences
04-Dec-2024 Elsevier adds 43 million Enamine make-on-demand compounds to Reaxys to accelerate chemistry R&D Elsevier
04-Dec-2024 VR key to training for advanced medicines manufacturing skills, says leading academic RESILIENCE
04-Dec-2024 From Patient Care to Planet Care: How IHH Healthcare is Redefining Healthcare Sustainability IHH Healthcare
04-Dec-2024 VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities VIVEbiotech
04-Dec-2024 Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications Synaffix
04-Dec-2024 Antag Therapeutics Announces €80 Million Series A Financing Antag Therapeutics